Mammoth Biosciences, based in Brisbane, Calif., was founded in 2017 by Trevor Martin, the company’s CEO, and Janice Chen, Lucas Harrington, and Jennifer Doudna. The company, which was last valued at $1.08 billion in September 2021, is developing novel CRISPR systems to cure and detect diseases. CRISPR is a tool that can allow researchers to alter DNA sequences and modify gene function.
In November, the company was named to Fast Company’s 2022 list of the “Next Big Things in Tech.” In September 2021, the company raised $150 million in Series D financing from a group of investors including Redmile Group, Foresite Capital, Greenspring Associates and Senator Investment Group.
These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
04/22/2024 | Series D-2 | $107.74MM | $xx.xx | $1.35B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
8,008,750
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|
||||||
09/09/2021 | Series D-1 | $37.5MM | $xx.xx | $1.08B | Redmile Group, Foresite Capital, Senator Investment Group, Sixth Street, Greenspring Associates, Mayfield, Decheng Capital, Plum Alley, NFX | |
Price per Share
$xx.xx
Shares Outstanding
2,787,461
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Redmile Group, Foresite Capital, Senator Investment Group, Sixth Street, Greenspring Associates, Mayfield, Decheng Capital, Plum Alley, NFX
|
||||||
09/09/2021 | Series D | $112.5MM | $xx.xx | $1.08B | Redmile Group, Foresite Capital, Senator Investment Group, Sixth Street, Greenspring Associates, Mayfield, Decheng Capital, Plum Alley, NFX | |
Price per Share
$xx.xx
Shares Outstanding
8,362,385
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Redmile Group, Foresite Capital, Senator Investment Group, Sixth Street, Greenspring Associates, Mayfield, Decheng Capital, Plum Alley, NFX
|
||||||
11/04/2020 | Series C-1 | $747,767 | $xx.xx | $278.7MM | NFX | |
Price per Share
$xx.xx
Shares Outstanding
192,530
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
NFX
|
||||||
11/04/2020 | Series C | $44.36MM | $xx.xx | $278.7MM | NFX | |
Price per Share
$xx.xx
Shares Outstanding
10,279,365
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
NFX
|
||||||
01/30/2020 | Series B-1 | $7.41MM | $xx.xx | $144.13MM | Decheng Capital, Mayfield, NFX, Vreily, Brook Byers, Plum Alley Investments, Pacific 8, aMoon | |
Price per Share
$xx.xx
Shares Outstanding
3,052,521
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Decheng Capital, Mayfield, NFX, Vreily, Brook Byers, Plum Alley Investments, Pacific 8, aMoon
|
||||||
01/30/2020 | Series B | $36.77MM | $xx.xx | $144.13MM | Decheng Capital, Mayfield, NFX, Vreily, Brook Byers, Plum Alley Investments, Pacific 8, aMoon | |
Price per Share
$xx.xx
Shares Outstanding
13,631,447
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Decheng Capital, Mayfield, NFX, Vreily, Brook Byers, Plum Alley Investments, Pacific 8, aMoon
|
||||||
08/08/2018 | Series A | $18.1MM | $xx.xx | $36.19MM | Plum Alley Investments | |
Price per Share
$xx.xx
Shares Outstanding
18,051,205
Liquidation Pref Order
5
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Plum Alley Investments
|